Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Account Payables (2016 - 2019)

Sunshine Biopharma filings provide 8 years of Change in Account Payables readings, the most recent being $33797.0 for Q4 2019.

  • On a quarterly basis, Change in Account Payables fell 49.57% to $33797.0 in Q4 2019 year-over-year; TTM through Dec 2019 was -$18692.0, a 130.33% decrease, with the full-year FY2020 number at -$35012.0, down 87.31% from a year prior.
  • Change in Account Payables hit $33797.0 in Q4 2019 for Sunshine Biopharma, up from -$21040.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $342944.0 in Q2 2017 to a low of -$359099.0 in Q3 2017.
  • Median Change in Account Payables over the past 5 years was -$146.5 (2017), compared with a mean of $2171.2.
  • Biggest five-year swings in Change in Account Payables: plummeted 6587.13% in 2018 and later skyrocketed 18113.93% in 2019.
  • Sunshine Biopharma's Change in Account Payables stood at $80616.0 in 2015, then tumbled by 65.52% to $27799.0 in 2016, then crashed by 41.27% to $16326.0 in 2017, then surged by 310.51% to $67020.0 in 2018, then tumbled by 49.57% to $33797.0 in 2019.
  • The last three reported values for Change in Account Payables were $33797.0 (Q4 2019), -$21040.0 (Q3 2019), and $21977.0 (Q2 2019) per Business Quant data.